C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancrea...
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
About this item
Full title
Author / Creator
Shirakawa, Tsuyoshi , Makiyama, Akitaka , Shimokawa, Mototsugu , Otsuka, Taiga , Shinohara, Yudai , Koga, Futa , Ueda, Yujiro , Nakazawa, Junichi , Otsu, Satoshi , Komori, Azusa , Arima, Shiho , Fukahori, Masaru , Taguchi, Hiroki , Honda, Takuya , Shibuki, Taro , Nio, Kenta , Ide, Yasushi , Ureshino, Norio , Mizuta, Toshihiko , Mitsugi, Kenji , Akashi, Koichi and Baba, Eishi
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
There are limited absolute biomarkers for determining the prognosis before first- and second-line palliative chemotherapy in unresectable pancreatic cancer (urPC) patients. To find the best prognostic inflammatory marker, we investigated relationships between overall survival (OS) and six inflammatory markers; C-reactive protein/albumin ratio (CAR)...
Alternative Titles
Full title
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Authors, Artists and Contributors
Author / Creator
Makiyama, Akitaka
Shimokawa, Mototsugu
Otsuka, Taiga
Shinohara, Yudai
Koga, Futa
Ueda, Yujiro
Nakazawa, Junichi
Otsu, Satoshi
Komori, Azusa
Arima, Shiho
Fukahori, Masaru
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Mizuta, Toshihiko
Mitsugi, Kenji
Akashi, Koichi
Baba, Eishi
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_bc6dd35d26fe4df2aa0b662a99f00fd2
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bc6dd35d26fe4df2aa0b662a99f00fd2
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-023-34962-7
